A carregar...
Benefits of AML Maintenance Therapy Extend to Quality of Life and Hospitalization
Maintenance therapy with oral azacitidine preserves quality of life and reduces hospitalization for patients with acute myeloid leukemia (AML) in first remission, according to updated findings from the phase III QUAZAR AML‐001 trial
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869115/ https://ncbi.nlm.nih.gov/pubmed/33368823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13653 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|